We initiated these studies to help clarify the roles of heme, ␦-aminolevulinic acid (ALA), hemA, and hemM in Escherichia coli heme synthesis. Using recombinant human hemoglobin (rHb1.1) as a tool for increasing E. coli's heme requirements, we demonstrated that heme is a feedback inhibitor of heme synthesis. Cooverexpression of rHb1.1 and the hemA-encoded glutamyl-tRNA (GTR) reductase increased intracellular levels of ALA and heme and increased the rate of rHb1.1 formation. These results support the conclusion that heme synthesis is limited by ALA ( 
In Escherichia coli and related bacteria, biosynthesis of heme (a generic term to denote either the ferrous or ferric form of protoporphyrin IX) occurs via a complex, branched pathway that involves up to 12 gene products (Fig. 1) . The committed precursor in the heme pathway, ␦-aminolevulinic acid (ALA), can be formed by either of two pathways. In E. coli, ALA is formed in three steps from the five-carbon skeleton of glutamate (C 5 pathway) (16, 20) . In Rhodobacter capsulatus (11) , ALA is formed by condensation of glycine and succinyl coenzyme A in a single enzymatic reaction (C 4 pathway) catalyzed by ALA synthase (15) . Seven additional reactions, including assembly of eight ALA molecules into a cyclic tetrapyrrole, modification of the side chains, and incorporation of reduced iron into the molecule, are required to convert ALA to heme.
The roles of ALA, glutamyl-tRNA (GTR) reductase, and heme in E. coli heme pathway regulation have been investigated and debated by several groups. ALA-feed studies performed during the early 1970s supported the conclusion that heme synthesis is limited by the rate at which ALA is formed. Wild-type E. coli cells fed ALA accumulated increased levels of heme and porphyrins (10, 21) . The regulatory role of ALA in heme synthesis was further supported by studies of heme synthesis in mammalian cells (7) and plant cells (2, 12) .
A more recent study by Hart and coworkers (9) challenged the conclusion that ALA is rate limiting for heme synthesis. Hart and coworkers genetically engineered E. coli cells to produce high levels of a foreign hemoprotein, Vitreoscilla hemoglobin (vHb), and found that such cells accumulated at least 20-fold more heme than control cells, indicating that the vHb served as a "heme sink" (9) . Contrary to what would be predicted from studies of E. coli cells with normal heme requirements, they found that E. coli cells expressing vHb failed to accumulate increased levels of heme when supplemented with high concentrations of ALA or when the copy numbers of certain heme biosynthetic enzymes (GTR reductase [hemA and hemM] or ALA dehydratase [hemB]) were greatly increased (9) .
The structure and regulation of the E. coli GTR reductase has also been the subject of considerable debate. Jahn and coworkers purified two GTR reductase activities of different molecular masses (85 and 45 kDa) (14) . Based on studies of the plant pathway (2, 12) , Jahn and coworkers expected the E. coli GTR reductase to be inhibited by heme. Surprisingly, they found that neither the 85-kDa nor the 45-kDa protein was inhibited by heme in vitro (14) . An E. coli gene specifying the 45-kDa enzyme (hemA) (26) but not the 85-kDa protein has been reported in the literature.
Two groups have suggested that the product of hemM is also involved in ALA formation (3, 13) . The deduced hemM product is a 23-kDa protein whose amino acid sequence is unrelated to any enzyme known to play a role in ALA synthesis (13) . The hemM gene is adjacent to and divergently transcribed from the hemA gene; the two genes are separated by 200 bp (13) . Based on the results of some complementation experiments, Ikemi and coworkers proposed that the hemM product is the major GTR reductase in E. coli and that the hemAencoded GTR reductase is involved in a minor ALA synthesis pathway (13) . Unfortunately, these investigators never demonstrated that the hemM-encoded protein has GTR reductase activity, and the DNA fragments used in their complementation studies contained portions of adjacent genes and open reading frames, which, in some cases, resulted in growth of a heterogeneous mixture of colony sizes (13) ; these type of results are often suggestive of recombination rather than complementation.
Chen and coworkers (3) attempted to clarify Ikemi and coworkers' findings (13) by subcloning hemA and hemM on separate plasmids. Unfortunately, the hemA-and hemM-containing plasmids used in Chen and coworkers' studies contained large portions of upstream and downstream genes. For example, their hemA-containing plasmid contained not only hemA but also the promoter and approximately half of the coding region of hemM, as well as a portion of an unrelated gene, prfA (3). Chen and coworkers observed that an E. coli hemA mutant containing multiple copies of a DNA fragment that included the complete hemA and hemM accumulated porphyrins faster, and to a higher level, than an isogenic mutant containing multiple copies of a DNA fragment that included all of hemA and a portion of hemM (3) . Based on these and other results, they concluded that the products of both hemA and hemM are required for maximal production of ALA (3). Because Chen and coworkers' complementation studies were performed with very high copy number cloning vectors (pUC derivatives), the increased levels of ALA observed in their studies may have been due to titration of a regulatory factor rather than increased production of a rate-limiting enzyme (3, 16) .
We initiated these studies to help clarify the roles of heme, ALA, hemA, and hemM in E. coli heme biosynthesis. Like Hart and coworkers (9), we performed our studies in E. coli cells expressing multiple copies of a heme sink, recombinant human hemoglobin (rHb1.1), so that cells would be spared from the toxic effects of high levels of free heme (27) that could accumulate as a result of our genetic manipulations. Moreover, to minimize the possibility of titration effects, which may have complicated other investigators' studies, we performed gene dosage experiments with medium-copy-number plasmids derived from p15A and used very discrete DNA fragments that included the genes of interest without flanking regions.
MATERIALS AND METHODS
Bacterial strains and plasmids. Bacterial strains and plasmids used in this study are listed in Table 1 . Although E. coli K-12 strains are typically impermeable to heme (23) , the strains evaluated in this work are heme permeable.
pSGE715 is a pUC-derived plasmid containing a synthetic, P tac -controlled operon composed of two genetically fused alpha subunits and one beta subunit of human hemoglobin and the lacI gene for repression of the tac promoter. pSGE518 was derived from pRS415 (25) by replacement of the EcoRI-SmaIBamHI cloning region with an EcoRI-HindIII-EagI-BglII-XhoI-HpaI-BamHI polylinker.
Genetic and recombinant DNA methods. P1vir transductions were performed according to standard methods (24) . Multicopy hemA-lacZ operon fusions were constructed in pSGE518, transferred to RS45 by homologous recombination, and then integrated as prophages into the chromosomal attachment site (att) according to published methods (25) .
Chromosomal DNA for PCR amplification was obtained by standard methods (24) . Oligonucleotides for PCR amplification and DNA sequencing were synthesized by using an Applied Biosystems model 392 DNA synthesizer (Applied Biosystems, Inc., Foster City, Calif.), using reagents obtained from Biogenex (San Ramon, Calif.) and methods recommended by the manufacturer.
All PCR amplification mixtures contained the following reagents: ϳ100 ng of template DNA, 20 to 50 pmol of each primer, 20 mM Tris-HCl, 10 mM KCl, 6 mM (NH 4 ) 2 SO 4 , 1.5 mM MgCl 2 , 0.1% Triton X-100, 0.2 mM each of the four deoxyribonucleoside triphosphates, and 2.5 U of Pfu polymerase (Stratagene Cloning Systems, La Jolla, Calif.) in a 100-l reaction volume. Thermocycling was performed with an Ericomp Twinblock system (Ericomp, San Diego, Calif.). Cycle conditions and primers are described below.
The BamHI-HindIII fragment in pSGE1103 was obtained by PCR amplification using primers TG40 and TG224 and SGE1670 chromosomal DNA as the template. Cycle conditions were as follows: 1 cycle of 5 min at 95°C, 5 min at 65°C, and 1 min at 75°C; 35 cycles of 1 min at 95°C, 30 s at 65°C, and 30 s at 75°C; and 1 cycle of 10 min at 75°C.
All three hemA promoter fragments (Fig. 3) were amplified by using the following cycle conditions (program J): 1 cycle of 5 min at 95°C, 5 min at 50°C, and 1 min at 72°C; 28 cycles of 1 min at 94°C, 1 min at 50°C, and 30 s at 72°C; and 1 cycle of 10 min at 72°C. The hemA promoter fragment in pSGE863 was amplified by using primers EV50 and EV39. The hemA promoter fragment in pSGE864 was amplified by using two sets of primers: (i) EV45 and EV57 and (ii) EV53 and EV54. The use of two primer sets allowed removal of a small DNA segment containing the hemA 1 transcription start site described by Verkamp and Chelm (26) .
The hemA gene fragment contained in pSGE494 was amplified by using program J and primers TG40 and TG41. The function of the hemA gene in pSGE494 was verified by complementation assay using an E. coli hemA mutant (data not shown).
A DNA fragment containing the coding sequence of hemA RC (the Rhodobacter gene that encodes ALA synthase [EC 2.3.1.37]) was obtained by PCR using chromosomal DNA isolated from R. capsulatus SB1003, primers EV98 and EV99, and program J (described above). In addition to confirming the DNA sequence of the hemA RC fragment in pSGE1110, we demonstrated that HemA RC allows an E. coli ALA auxotroph to grow without ALA supplementation (data not shown). Li and coworkers had previously shown that the R. sphaeroides ALA synthase could complement an E. coli hemA mutant for growth (16) .
Primers and cycle conditions used for amplification of the BamHI-HindIII fragment in pSGE1104 were as follows: EV113 and TG224; one cycle of 5 min at 95°C, 5 min at 60°C, and 3 min at 72°C, 33 cycles of 30 s at 95°C and 30 s at 60°C, and a final cycle of 8 min at 72°C.
Plasmid DNA for cloning and DNA sequencing was isolated by using a Wizard plasmid isolation kit (Promega, Madison, Wis.) according to the manufacturer's instructions. Restriction digests, gel electrophoresis, DNA ligations, and transformations were performed according to standard methods (22) . PCR fragments and restriction fragments for ligation reactions were purified by using a Geneclean II kit (Bio 101, Vista, Calif.). Both strands of DNA fragments generated by PCR were sequenced by using the Prism DYE-terminator cycle sequencing system (Applied Biosystems) and an Applied Biosystems model 373 automated sequencer. DNA sequences were analyzed with programs contained in the MacVector (version 4.5.2) software package (International Biotechnologies Inc., New Haven, Conn.).
␤-Galactosidase assays. Strains were grown overnight in 5 ml of M63 salts (19) supplemented with 0.4% glucose, 0.1% Casamino Acids, 50 g of proline per ml, 40 g of thiamine per ml, 1 mM MgSO 4 , and appropriate antibiotics. Cells were diluted 1:50 into test tubes containing 5 ml of the same medium and grown at 37°C with shaking to an optical density at 600 nm (OD 600 ) of 0.4 to 0.8. Cultures were assayed for ␤-galactosidase as described by Miller (19) .
Media and growth conditions. Shake-flask-scale experiments were performed in 50 ml of DM-1 (18) in 250-ml Erlenmeyer flasks. Cultures were grown at 30°C with shaking to an OD 600 of ϳ0.6, induced with 300 M isopropyl-␤-D-thiogalactopyranoside (IPTG), and grown for an additional 4 h. At harvest, final culture densities (measured at OD 600 ) were between 2.8 and 4.0. ALA (Sigma Chemical Co., St. Louis, Mo.) was solubilized in water, filter sterilized, and added to cultures to yield solutions with final concentrations of 0.02, 0.10, 0.39, 1.56, 6.25, 4 . Glucose was added to a final concentration of 1% (wt/vol); thiamine was added to a final concentration of 0.32 mg/ml. Antibiotics (Sigma) were added, when necessary, in the following concentrations: tetracycline, 15 g/ml; chloramphenicol, 25 g/ml; and ampicillin, 100 g/ml.
The primary-seed-stage culture was grown at 30°C with shaking for 8 to 10 h or until the OD 600 was 0.8 to 1.5, and 400 ml of culture was used to inoculate a secondary seed stage: a 2-liter Bioflo III fermentor (New Brunswick, Edison, N.J.) containing 1,600 ml of DM59 medium supplemented with 1% (wt/vol) glucose, trace metals (in concentrations described above), and appropriate antibiotics. The pH of the secondary-seed-stage culture was maintained at 6.8 by using a base feed of 15% (vol/vol) NH 4 OH. Dissolved oxygen was maintained at 20% in 2-liter fermentors.
The secondary-stage-culture was grown to an OD 600 of 5 to 10, and a 500-ml aliquot was used to inoculate the final stage culture: a 15-liter fermentor (LSL Biolafitte) containing 8 liters of DM59 medium. Glucose was added to 15-liter fermentors at a starting concentration of 2.0 g/liter and maintained thereafter at 2 to 10 g/liter. The pH and dissolved oxygen concentrations of 15-liter fermentors were maintained as described above. When cultures reached an OD 600 of ϳ30, IPTG (Sigma) was added to a final concentration of 100 M to induce rHb1.1 expression.
Heme, obtained as bovine hemin (Amresco, Solon, Ohio), was dissolved in 1 N NaOH to a final concentration of 50 mg/ml. Where specified, heme was added to fermentors at the time of IPTG induction, and at 3 and 6 h postinduction, as 10-, 13-, and 17-ml aliquots. Cell pellets were collected and stored at Ϫ70°C until analyzed.
ALA and PBG assays. One-milliliter fermentation samples were resuspended in 10 mM morpholineethanesulfonic acid (pH 6.0) and used for assays. Lysozyme, NaCl, and DNase were added to final concentrations of 500 g/ml (lysozyme), 100 mM (NaCl), and 60 g/ml (DNase), and samples were incubated on ice for 20 min and then at 37°C for 2 min. Proteinase K (Sigma) was added to a final concentration of 150 g/ml, and samples were incubated for an additional 20 min on ice. The sample pH was lowered to 5.5 to 5.9 by addition of 10% acetic acid. Samples were freeze-thawed and then centrifuged for 10 min at 13,000 ϫ g at 4°C. The supernatant was removed, and ALA and porphobilinogen (PBG) were separated by using a two-column chromatography system (ALA/ PBG by Column Test Kit) obtained from Bio-Rad (Hercules, Calif.). ALA and PBG levels were quantified by their reactivity with Ehrlich's reagent, essentially as described in the protocol for the Bio-Rad test kit.
Heme extraction. Forty-milliliter samples of shake flask cultures were harvested by centrifugation at 13,000 ϫ g for 5 min, and pellets were stored for 1 to 5 days at Ϫ20°C. The pellets were thawed on ice, resuspended in 1 ml of acetone-1 N HCl (9:1), and vortexed vigorously for 45 s. After a 1-h incubation on ice, the samples were vortexed again and centrifuged (13,000 ϫ g) for 10 min. The supernatants were transferred to fresh tubes, and 25-l aliquots were analyzed by reversed-phase high-performance liquid chromatography. Recovery of heme from spiked samples was greater than 90% under these conditions (data not shown).
Heme quantitation. Samples prepared by the method described above were injected onto a Hypersil ODS column (5 m; 2.1 by 150 mm; Alltech Associates, Deerfield, Ill.) equilibrated with acetonitrile-methanol-H 2 O (1:1:40) and 0.1% (vol/vol) trifluoroacetic acid. After injection, the solvent was changed to acetonitrile-methanol (1:1)-0.1% (vol/vol) trifluoroacetic acid, with a linear gradient over 4 min. Elution with the second buffer continued for 11 min at a flow rate of 0.5 ml/min. Elution was monitored at 404 nm with a Hewlett-Packard model 1090 diode array detector (Hewlett-Packard, Palo Alto, Calif.). Bovine hemin (Amresco) was dissolved in 0.1 N NaOH, quantified spectrophotometrically (6), and used as the standard for heme measurements. The heme values reported represent total, extractable heme present in the cell.
Hemoglobin assay. Samples (1 ml of fermentation broth at an OD 600 of ϳ70) were pelleted and resuspended in 25 mM Na 2 B 4 O 7 . Lysozyme and NaCl were added to final concentrations of 1 mM NaCl and 0.75 mg of lysozyme per ml, and the samples were incubated first at 4°C (30 to 40 min) and then at 37°C (3 min). DNase (60 g/ml) was added, and the samples were incubated 15 min at room temperature. The samples were freeze-thawed, treated for 10 s with CO gas, and then diluted into a solution of 80 mM Tris Cl-2 M NaCl (pH 8.0). The crude lysates were heated at 65°C for 4 min and centrifuged at 13,000 ϫ g for 2 min to remove cellular debris and contaminating proteins. The supernatant fraction containing partially purified hemoglobin was saved, and the hemoglobin was quantified by immobilized metal chelate chromatography using a Biocad perfusion chromatography workstation (PerSeptive Biosystems, Cambridge, Mass.).
The capture column was charged with a solution of 20 mM zinc acetate-200 mM NaCl and equilibrated with 8 mM Tris-HCl-200 mM NaCl (pH 8.0). Samples were loaded onto the column in the same buffering system used for column equilibration, and the column was washed with 20 mM Tris-HCl-500 mM NaCl (pH 8.0). Hemoglobin was eluted from the column with 40 mM Tris-HCl-1 M NaCl-25 mM EDTA (pH 8.3). Hemoglobin elution was monitored at 412 nm.
RESULTS
Role of heme in pathway regulation. Plasmid pSGE715 is a high-copy-number plasmid for IPTG-controlled expression of the alpha and beta subunits of human hemoglobin. Following IPTG induction, E. coli strains containing pSGE715 produce large quantities of fully functional tetrameric hemoglobin (rHb1.1). Because each hemoglobin tetramer has the capacity to bind four heme groups, induction of rHb1.1 is expected to rapidly deplete cellular pools of heme. Accordingly, if heme is a repressor of E. coli heme synthesis, removal of heme by a heme sink is expected to activate heme synthesis. Our results are similar to those of Hart and coworkers (9) and consistent with the hypothesis that heme is a negative regulator of the heme pathway. Prior to induction of rHb1.1, shake flask cultures of SGE1453 contain approximately 25 pmol of heme/ OD 600 /ml (Fig. 2) . Four hours following induction of rHb1.1, cultures of SGE1453 have approximately 75 pmol of heme/ OD 600 /ml (Fig. 2) .
Effect of exogenous ALA on heme synthesis. We examined the effect of ALA levels on heme synthesis by feeding shake flask cultures various quantities of ALA and then monitoring cellular heme levels 4 h after induction of rHb1.1. Maximal heme accumulation occurred with 6.25 g of ALA per ml; higher levels of ALA resulted in no additional increase in heme pools (Fig. 2) . These results imply that ALA formation limits heme synthesis. In our studies, ALA supplementation resulted in a threefold increase in cellular heme (Fig. 2) . The effects of ALA supplementation and the heme sink were approximately additive. Cultures expressing rHb1.1 which were supplemented with 6.25 g of ALA per ml contained approximately sevenfold more heme than an uninduced, unsupplemented control.
Role of GTR reductase in heme synthesis. Like Hart and coworkers (9), we were interested to know if increasing ALA pools by genetically manipulating enzymes involved in ALA formation, especially the GTR reductase, would have a greater effect on cellular heme content than supplementation with exogenous ALA. Accordingly, plasmids for overexpression of the hemA and hemM genes from their native promoters were constructed and evaluated in fermentation cultures. In contrast to other investigators (3, 9, 13), we used medium-copy-number plasmids and were careful to exclude extraneous flanking sequences that might complicate our evaluations. The hemA (pSGE494) and hemM (pSGE1104) plasmids used in this work contained the complete coding sequences of the relevant gene and 200 bp of upstream DNA. The hemA hemM plasmid (pSGE1103) included the complete hemA and hemM coding regions and the 200 bp of DNA that normally separate those two genes.
In our studies, cells expressing a heme sink and containing multiple copies of either hemA alone or hemA and hemM together accumulated large intracellular pools of ALA relative to a control (Table 2) . Because ALA accumulated before and after induction of the heme sink, we conclude that multiple copies of hemA (SGE2664) or hemA plus hemM (SGE2658) result in constitutive expression of GTR reductase and accumulation of ALA (Table 2) . Control strains (SGE1453) had undetectable levels of ALA prior to induction of the heme sink and only low levels of ALA postinduction. No significant differences in the ALA pools were found when cells containing multiple copies of hemA (SGE2664) and multiple copies of hemA plus hemM (SGE2658) were compared ( Table 2) . ALA pools in SGE2680, which expresses hemM and rHb1.1, were similar to those in a control strain (SGE1453) both pre-and postinduction ( Table 2) . Pools of other pathway intermediates (uroporphyrinogen III, coproporphyrinogen III, and protoporphyrin IX) were indistinguishable in strains SGE1453, SGE2644, SGE2658, and SGE2680 (data not shown).
Purification of HemM has not yet been reported, and no antibodies or enzyme assays are available for monitoring expression of the protein. We were therefore unable to verify HemM function by enzyme assay or Western analysis. We can, however, provide indirect evidence to support expression of HemM from the hemM plasmids evaluated in this study. We fused a DNA fragment containing the 200-bp region upstream of the hemM start codon and the first 18 codons of the hemM coding sequence to codon 9 of the lacZ gene in pMLB1034 (28) to create a hemM-lacZ protein fusion. A wild-type strain containing this hemM-lacZ fusion produced 6,118 Ϯ 492 Miller units of ␤-galactosidase activity, while a control strain containing the pMLB1034 vector produced less than 1 U of activity.
We found that cells expressing rHb1.1 and either HemA (SGE2664) or HemA plus HemM (SGE2658) contained more heme (Table 2 ) and accumulated rHb1.1 at a faster rate than a control strain (Table 3) . We do not believe that multicopy hemA-hemM has a greater effect on rHb1.1 accumulation than multicopy hemA. When HemM and rHb1.1 were expressed in the same cell (SGE2680), the rate of rHb1.1 accumulation was no faster than in a strain expressing only rHb1.1 (SGE1453).
Based on these data, we conclude that ALA formation is a rate-limiting step and that the hemA-encoded GTR reductase is a rate-limiting enzyme in the E. coli heme pathway. Feeding exogenous heme to cells overexpressing hemA plus hemM and rHb1.1 (SGE2658) had no effect on intracellular ALA levels ( Table 2) . Because cultures of an isogenic strain, SGE1453, produce rHb1.1 at a higher rate when supplemented with heme (Table 3) , we believe that SGE2658 is capable of taking up exogenous heme, and we conclude that ALA formation in E. coli is not repressed by heme.
Effects of exogenous ALA and heme on hemA expression. Using the method of S1 nuclease protection, Verkamp and Chelm identified two potential transcription start sites, Ϫ38 and Ϫ131, and two 70 consensus promoters (hemA 1 and hemA 2 ) for the hemA gene in aerobically growing E. coli cells (26) . The hemA 1 and hemA 2 promoters were proposed to lie at nucleotides Ϫ45 to Ϫ70 and Ϫ145 to Ϫ173, respectively, relative to the hemA start codon (26) . A divergent transcript which started 83 nucleotides upstream of the hemA 2 promoter on the opposite strand was also detected (26) . This divergent a ALA and PBG assays in the absence of IPTG were measured at induction (OD 600 , ϳ30). ALA and PBG values for SGE2680 represent the averages of two experiments. All other ALA and PBG values represent the averages of at least four trials. Variation for ALA and PBG measurements is given as the standard error. ALA and PBG assays in the presence of IPTG were performed on cells 8 h after induction of the heme sink. Samples for heme measurements were collected 8 h after induction of the heme sink. Four to eight replicate fermentations were performed for each strain reported. Heme measurements reflect total extractable heme found in the cell. Variation is reported as the standard error. ND, not detectable; NT, not tested.
b Heme was added to fermentors as described in Materials and Methods. Values are the averages of eight fermentation trials. a Four to eight replicate fermentations were performed for each strain reported. rHb1.1 measurements were made during the 8-h period following induction. Slopes and variation were obtained from linear regression lines with correlation coefficients ranging from 0.72 to 0.97.
b Heme was added to cultures as described in Materials and Methods. Results are the averages of four fermentation trials.
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REGULATION OF E. COLI HEME SYNTHESIS 4587 transcript was shown to encode a 23-kDa protein, hemM, and a role for HemM in ALA synthesis was proposed (3, 13) .
To assess the biological relevance of the two potential hemA promoters, we fused 244 nucleotides of the hemA coding sequence and 158 to 230 nucleotides of sequence 5Ј of the hemA start codon to the E. coli lacZ gene and then transferred those fusions to the E. coli chromosome (Fig. 3) . Three different hemA-lacZ fusions were constructed. One fusion (SGE1858) included the hemA 1 promoter, one (SGE1859) included the hemA 2 promoter, and one (SGE1857) included both the hemA 1 and hemA 2 promoters. Because a hemA mutant requires ALA supplementation for growth, our initial analyses of these fusions were performed in a hemA ϩ host. ␤-Galactosidase activity assays indicated that both the hemA 1 and hemA 2 promoters are biologically active and that the hemA 1 promoter is the stronger promoter (Table 4) . Similar results were obtained when the three hemA-lacZ fusions were integrated into the genome of a hemA mutant and grown with 0.2 g of ALA per ml (data not shown). A control plasmid containing the 244 nucleotides of hemA coding sequence fused to lacZ produced approximately 10% of the ␤-galactosidase activity produced by a similar plasmid containing the weaker of the two hemA promoters (hemA 2 ) fused to lacZ (data not shown). Our results are similar to Choi and coworkers' findings about the importance of the hemA P1 promoter in high level expression of the Salmonella typhimurium hemA (4) .
The effects of exogenous ALA and heme on hemA expression were evaluated in hemA mutants containing single-copy hemA-lacZ fusions. We found that the hemA 1 but not the hemA 2 promoter is regulated in response to the intracellular level of ALA. Expression of a hemA 1 -lacZ (SGE1861) fusion was activated approximately twofold when the concentration of ALA was decreased (Fig. 4) , while expression of a hemA 2 -lacZ (SGE1862) fusion was unaffected by the ALA concentration (Fig. 4) . Addition of exogenous heme (40 g/ml) to cultures of SGE1861 (hemA 1 -lacZ) grown in a glucose minimal medium containing ALA (either 0.2 or 0.05 g/ml) did not reduce expression of any of the hemA-lacZ fusions tested, suggesting that hemA gene expression may not be regulated by heme (data not shown).
Overexpression of ALA synthase. In contrast to E. coli, Rhodobacter synthesizes ALA by the C 4 or Shemin pathway ( Fig. 1) (15) . E. coli hemA mutants, which require ALA supplementation for growth, can be complemented by hemA RC (11, 16) . Thus, E. coli can produce heme by using enzymes from either the C 4 or C 5 pathway. We placed hemA RC under control of the tac promoter to create an inducible system for studying the effect of high-level expression of ALA synthase on heme pathway regulation.
ALA and PBG pools in cells expressing hemA RC (SGE2681) were significantly higher than in a control strain (SGE1453) following induction of HemA RC and the heme sink (Table 2) . Although strains expressing HemA RC and the heme sink (SGE2681) produced more heme, the rates of rHb1.1 accumulation for strains SGE1453 and SGE2681 were indistinguishable (Table 2) . Interestingly, we found that the ratios of ALA and PBG in cells expressing hemA (SGE2644), hemA plus hemM (SGE2658), and hemA RC (SGE2681) were considerably different. Strains SGE2644 (hemA) and SGE2658 (hemA hemM) accumulated very large pools of ALA and smaller pools of PBG, while SGE2681 (hemA RC ) accumulated large pools of both ALA and PBG (Table 2 ). An SGE1453 control strain failed to accumulate PBG either before or after induction, and ALA pools were low or undetectable pre-and postinduction.
DISCUSSION
Results described in this work support the hypothesis that ALA formation is a rate-limiting step in E. coli heme biosynthesis (10, 17, 21) . Based on studies similar to ours, Hart and coworkers concluded that ALA synthesis is not a rate-limiting step (9) . Hart and coworkers observed that E. coli cells expressing high levels of a heme sink (vHb) were impaired in their abilities to accumulate heme when supplemented with ALA. Hart and coworkers used 10 to 100 mM ALA in their studies; we used ALA at a concentrations of 0.025 to 0.5 mM (Fig. 2) . Based on the results of Harris and coworkers (8) , who observed that pseudomonads fed concentrations of ALA in excess of 2 mM were impaired in growth and porphyrin production, we suggest that Hart and coworkers may have used an excessively high concentration of ALA.
In contrast to our studies, Hart and coworkers observed no increase in heme accumulation when they overexpressed a heme sink and provided increased copies of hemA and hemM (9) . The differences in our results may be related to differences in gene dosage and/or to the amounts of ALA that accumulated in cells. Hart and coworkers expressed hemA and hemM, and the heme sink, from a single, very high copy number plasmid (9) . In our studies, the hemA gene and the hemA and hemM genes were expressed separately from the heme sink, on medium-copy-number plasmids.
Although ALA measurements were never monitored, Hart and coworkers assumed that the intracellular ALA level was sufficiently high to create a new pathway limitation at the hemB-catalyzed step (9) . In follow-up experiments in which hemA, hemM, hemB, and the heme sink were expressed from a single high-copy-number plasmid, they observed a significant decrease in heme accumulation. Unfortunately, no measurements of ALA or PBG were performed, and so the effects of the additional gene copies could not be evaluated thoroughly (9) . We suspect that the decrease in heme accumulation may be due, in part, to the increased metabolic burden imposed by their expression plasmid (1).
Our results do not support the hypothesis that both hemA and hemM are required for maximal accumulation of ALA (3). We observed an enhancement in ALA accumulation when cells were provided with multiple copies of hemA but no further enhancement when both hemA and hemM were provided. We note that, in contrast to the studies of Chen and coworkers (3), our hemA hemM plasmid was of moderate copy number, and the cloned DNA fragment lacked any sequences beyond the natural stop codons present in hemA and hemM. Chen and coworkers' plasmid contained a portion of prfA and an uncharacterized open reading frame, either of which may have contributed to their results (3). Moreover, it remains possible that Chen and coworkers' results were due to titration of a regulatory factor by a sequence present on their very high copy number plasmid (3) .
Like Chen and coworkers, we found that a hemM-containing plasmid was unable to complement a hemA mutant (data not shown) and that wild-type cells containing multiple copies of hemM did not accumulate larger amounts of ALA (3). Our results do not support Ikemi and coworkers' conclusion that hemM encodes a GTR reductase (13) .
We found that intracellular ALA levels in cultures containing multiple copies of hemA plus hemM were not reduced by exogenously supplied heme. Based on results presented earlier in the text, we feel confident that the exogenous heme was taken up by cells. When considered together with Jahn and coworkers' in vitro results (14) , these data suggest that the E. coli GTR reductase may be insensitive to heme levels and thus regulated differently from other GTR reductase enzymes (2, 12) .
Two genetic systems for increasing ALA pools, hemA and hemA RC , were evaluated in this study. Although both systems allowed for an increase in cellular heme content, the two systems had different effects on rHb1.1 accumulation. The strong tac promoter that drives the hemA RC gene in pSGE1110 is probably much more efficient than either the hemA 1 or hemA 2 promoter, neither of which has ideal Ϫ10 or Ϫ35 consensus elements (26) . It is possible that the level of HemA RC protein produced by pSGE1110 is so high that the cell's capacity to produce rHb1.1 is compromised, even though the cell accumulates more heme. In support of this hypothesis, we note that others have observed a decrease in protein synthetic capacity in cells expressing genes from very strong promoters (5).
Harris and coworkers (8) found that supplementation of Pseudomonas cultures with large quantities of ALA increased heme pathway flux and led to excretion of high levels of porphyrins, with uroporphyrinogen I, a nonenzymatically formed pathway intermediate which is physiologically nonrelevant, appearing as the predominant product (8) . In some strains, a significant amount of this incorrect isomer could be further processed. Based on these findings, Harris and coworkers proposed that high levels of ALA saturate the enzymatic machinery that normally converts four PBG molecules to the physiologically relevant uroporphyrinogen III (8) . It is possible that IPTG induction of hemA RC provides a sufficiently high quantity of ALA to overload the enzymatic machinery that converts PBG to heme, for example, by allowing formation of incorrect isomers which cannot be further processed or incorporated into rHb1.1. It is possible that Hart and coworkers' experimental design also allowed for the production of incorrect isomers (9) . Our analytical methods do not allow us to discriminate among the various porphyrin isomers.
